Pharma Sector
Advertisement
India Sees 10% Rise in White-Collar Hiring in October; Fresher Jobs Increase by 6%
Roles in AI/ML saw exceptional growth at 39% year-on-year and 2% month-on-month according to data by The Naukri JobSpeak Index.
Indian Pharma Market Sees 5.1% Growth in September
The industry grew 7.7 per cent year on year in the 12 months ending in September, led by price growth and new launches. However, volume growth was moderate at 0.8 per cent on-year last month, according to the report by Motilal Oswal Financial Services Ltd.
Increased App Restorations on Play Store Following Google's Billing Compliance; IAMAI Raises Worries
Murugavel J, the founder and CEO of matrimony.com, disclosed that only eight apps from their portfolio, including Bengali Matrimony, Marathi Matrimony, Tamil Matrimony, Jodii, and Bharat Matrimony, were reinstated upon accepting Google's terms. Despite this, the majority of their 100-plus apps are yet to be restored on the Play Store, he stated.
Pharma firms valuations do not factor in threats from acceleration in generics adoption in India
In another instance exemplifying the Indian government’s intent to push generics, it has set an imposing timeline to achieve its objective of reaching 25,000 Jan Aushadhi stores. The government targets to increase the store count by 2.5X to 25,000 in less than 2.5 years (end-FY2026), the report said.
US pharma giant Viatris inks 2 deals to sell India business for $1.2 bn
The United States-headquartered global healthcare company has centres in Pittsburgh, Shanghai, and Hyderabad.
US fines Teva, Glenmark $255 mn over drug price-fixing charges
The Department of Justice (DoJ) announced that Teva will also make a $50 million drug donation to humanitarian organisations, along with a $225 million criminal penalty -- the largest to date for a domestic antitrust cartel. Glenmark will pay $30 million to resolve charges alleging that it conspired with Teva to fix prices for that cholesterol drug, called pravastatin.
Pfizer, Gilead, GSK to lead $150 bn infectious diseases mkt by 2029: Report
The report by GlobalData, a leading data and analytics company, showed that the infectious diseases market is forecast to grow at a compound annual growth rate (CAGR) of 5.7 per cent between 2023 and 2029 to reach an impressive $150 billion in annual sales in 2029.
Licences of 18 pharma companies suspended over drug quality
A top official source on Tuesday said that the Drug Controller General of India had inspected 76 companies and the licence of 18 have been suspended, while 26 have been served show cause notice over poor quality of drugs. The Centre has also cancelled the product permission of three pharma companies.
Advertisement